[go: up one dir, main page]

DE68901145D1 - Verfahren zur herstellung von arzneimitteldurchlaessigen materialien. - Google Patents

Verfahren zur herstellung von arzneimitteldurchlaessigen materialien.

Info

Publication number
DE68901145D1
DE68901145D1 DE8989300448T DE68901145T DE68901145D1 DE 68901145 D1 DE68901145 D1 DE 68901145D1 DE 8989300448 T DE8989300448 T DE 8989300448T DE 68901145 T DE68901145 T DE 68901145T DE 68901145 D1 DE68901145 D1 DE 68901145D1
Authority
DE
Germany
Prior art keywords
medium
production
permeable materials
permeable
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989300448T
Other languages
English (en)
Inventor
Yosuke Urabe
Hiroyuki Kawashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DuPont Toray Specialty Materials KK
Dow Silicones Corp
Original Assignee
Dow Corning Asia Ltd
Dow Corning Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Asia Ltd, Dow Corning Corp filed Critical Dow Corning Asia Ltd
Application granted granted Critical
Publication of DE68901145D1 publication Critical patent/DE68901145D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04—Polysiloxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
DE8989300448T 1988-01-21 1989-01-19 Verfahren zur herstellung von arzneimitteldurchlaessigen materialien. Expired - Lifetime DE68901145D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP947988A JPH01186823A (ja) 1988-01-21 1988-01-21 薬物透過性物質の製造方法

Publications (1)

Publication Number Publication Date
DE68901145D1 true DE68901145D1 (de) 1992-05-14

Family

ID=11721390

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989300448T Expired - Lifetime DE68901145D1 (de) 1988-01-21 1989-01-19 Verfahren zur herstellung von arzneimitteldurchlaessigen materialien.

Country Status (3)

Country Link
EP (1) EP0326278B1 (de)
JP (1) JPH01186823A (de)
DE (1) DE68901145D1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162456A (en) * 1992-09-24 2000-12-19 Ortho-Mcneil Pharmaceutical, Inc. Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
WO2000024437A2 (en) * 1998-10-28 2000-05-04 Ashby Scientific Ltd. Textured and porous silicone rubber
JP2001240533A (ja) 2000-02-29 2001-09-04 Kao Corp 経皮投与型製剤
US7857856B2 (en) 2005-03-15 2010-12-28 Warsaw Ortho Pedic, Inc. Composite spinal nucleus implant with water absorption and swelling capabilities
CN115154663B (zh) * 2022-07-05 2023-02-07 中国科学院化学研究所 具有双相药物缓释功能的水凝胶型组织工程支架及其光固化3d打印制备方法、光敏树脂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
IE58536B1 (en) * 1986-06-09 1993-10-06 Chanelle Chemicals Ltd Subcutaneous implant

Also Published As

Publication number Publication date
JPH01186823A (ja) 1989-07-26
EP0326278A1 (de) 1989-08-02
EP0326278B1 (de) 1992-04-08

Similar Documents

Publication Publication Date Title
DE58906156D1 (de) Verfahren zur Herstellung von Membranen.
DE68914379D1 (de) Verfahren zur Herstellung von Sinterkörpern.
DE3782092D1 (de) Verfahren zur herstellung von wasserabsorbierenden materialien.
DE58902544D1 (de) Verfahren zur herstellung von 4-alkoxy-2-hydroxybenzophenon-5-sulfonsaeuren.
DE68924619D1 (de) Stereolithographisches Verfahren zur Herstellung von Prothesen.
DE58906148D1 (de) Verfahren zur Herstellung von Aminen.
DE58908451D1 (de) Verfahren zur Herstellung von Organochlorsilanen.
DE68921655D1 (de) Verfahren zur Herstellung von Mustern.
DE58906613D1 (de) Verfahren zur Herstellung von orthodontischen Teilen.
DE68913447D1 (de) Verfahren zur Herstellung von Halofluorbenzolen.
DE68920351D1 (de) Verfahren zur Herstellung von Indigoverbindungen.
DE58906418D1 (de) Verfahren zur Herstellung von Festkörpern.
DE68918050D1 (de) Verfahren zur Herstellung von Windschutzscheiben.
DE68916760D1 (de) Verfahren zur Herstellung von Gamma-Lactonen.
DE3881091D1 (de) Verfahren zur herstellung von phosphatidsaeurederivaten.
DE69009153D1 (de) Verfahren zur Herstellung von künstlichen Diamanten.
DE3885262D1 (de) Verfahren zur Herstellung von 2-Chlor-5-methyl-pyridin.
DE58904105D1 (de) Verfahren zur herstellung von hexafluorpropen.
DE58906122D1 (de) Verfahren zur Herstellung von Phenylethanolen.
DE68924644D1 (de) Verfahren zur herstellung von polyarylenthioäther.
DE68910919D1 (de) Verfahren zur Herstellung von Pigment.
DE68901145D1 (de) Verfahren zur herstellung von arzneimitteldurchlaessigen materialien.
DE68920298D1 (de) Verfahren zur Herstellung von 4-Acetoxyazetidinonen.
DE3862774D1 (de) Verfahren zur herstellung von vinylphosphonsaeuredialkylestern.
DE58905592D1 (de) Verfahren zur Herstellung von N-Hydroxypyrazolen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee